Learn more about E-DENGUE, a digital tool we're supporting that can help predict where potential dengue outbreaks might happen.
- Reports and financial statements relating to our work in the year from 1 October 2022 to 30 September 2023.
Who this is for
- Anyone who is interested in what impact Wellcome is having on our mission of supporting science to solve the urgent health challenges facing everyone, as well information about how we are funded and what we spent in the last financial year.
The first year in Wellcome's decade-long plan to spend £16 billion saw charitable spend increase.
- In 2022/23, Wellcome spent £1.7 billion supporting ambitious discovery research into life, health and wellbeing, and actions taking on the urgent health challenges facing everyone – climate and health, mental health and infectious diseases.
- Our major funding announcements in 2023 included the commitment of up to £126 million for a large-scale trial for what could be the first new tuberculosis vaccine in 100 years.
- We also saw two major breakthroughs for child health globally – against malaria and mitochondrial disease – which were supported by Wellcome’s long-term commitment to Discovery Research.
- Our senior appointments included Dr Jimmy Volmink in the newly formed role of Chief Equity, Diversity and Inclusion Officer.
- Wellcome’s culture and approach is now also strengthened by a clearer articulation of our beliefs and values.
Examples of our work in 2022/2023
Find out about the multimillion-pound global study funded by Wellcome and the Bill & Melinda Gates Foundation that seeks to advance a new tuberculosis vaccine.
Dr Rimona Weil explains how Wellcome's Career Development Award is supporting her to use advanced neuroimaging to better understand Parkinson's dementia.
Discover the twelve research projects we're funding to investigate what makes interventions for anxiety, depression and psychosis effective.